Lightnews — Scholar-powered news

Michael G. Ison, MD MS

@michaelisonmd.bsky.social

1.3K followers 610 following 61 posts

Transplant Infectious Diseases MD, clinical respiratory virologist and Editor-in-Chief of @TheTxIDJournal.bsky.social. All opinions and tweets are my own.

Posts Media Videos Starter Packs

Pinned

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Mar 19

Do you have ideas for sessions about infections in immunocompromised hosts for @escmid.bsky.social Global 2026? ESGICH is looking for people to help with session planning and concepts.

To participate in the planning: forms.gle/1gAUw3UuBdxk...

To submit a concept: forms.gle/SyFjuxnbUuCD...

ESGICH Planning Committee for 2026 ESCMID Global

This will be a small working group to help develop proposals for ESGICH to propose for the 2026 ESCMID Global Program. If you are interested in help, please complete the form below. This will be o...

forms.gle

5 10

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 12d

Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!

Transplant Infectious Disease Journal @thetxidjournal.bsky.social · 12d

@thetxidjournal.bsky.social is seeking applications for those interested in joining the editorial team (onlinelibrary.wiley.com/page/journal...) as an Associate Editor. We are specifically seeking someone who has clinical and research experience focused on HSCT/Oncology ID for this position.

1/4

Transplant Infectious Disease Editorial Board

Michael G. Ison MD, MS, Washington, DC, USA

onlinelibrary.wiley.com

1 1 5

Reposted by Michael G. Ison, MD MS

Brad Gardiner @bradgardiner.bsky.social · Sep 3

check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with
@michaelisonmd.bsky.social
on this! #TxID doi.org/10.1016/j.jh...

Redirecting

doi.org

1 4

Michael G. Ison, MD MS @michaelisonmd.bsky.social · 22d

The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.

2 5

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Aug 15

Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses.

www.sciencedirect.com/science/arti...

Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation

Lung transplantation (lung-tx) offers the last life-saving option for patients with COVID-19-associated lung injury (CALI). We show that the RBD-speci…

www.sciencedirect.com

1 2

Reposted by Michael G. Ison, MD MS

American Journal of Transplantation @amjtransplant.bsky.social · Jul 10

AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate.

ajt-transplant-id-exchange.squarespace.com

8 9

Reposted by Michael G. Ison, MD MS

Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · Aug 3

Don't miss the new @amjtransplant.bsky.social #TxID blog led by Emily Blumberg ajt-transplant-id-exchange.squarespace.com #wtc2025 @ast-idcop.bsky.social @ast-tyfcop.bsky.social @astinfo.bsky.social

AJT Transplant ID Exchange

ajt-transplant-id-exchange.squarespace.com

6 13

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Aug 1

Excited to head to San Francisco for #WTC2025 @ast-idcop.bsky.social

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 14

Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs.

www.science.org/doi/10.1126/...

1 1 12

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 14

Likewise, screening for FQ resistance may inform what breakthrough infections will occur and optimize early management.

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 14

Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.

2 1 10

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 14

Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.

1 6

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 13

Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs

onlinelibrary.wiley.com/doi/10.1111/...

1 2 13

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 13

The future may be using the tool to look at pathogen and host response in the same assay - multiple examples shown that the combined approach provided answers that wouldn’t have been identified.

1 4

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 13

Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.

1 2 6

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 12

Amazing talk on aging and infection Maheen Abidi - many questions and need for data to inform management approaches. @fredhutch.bsky.social Symposium of Infections in ICH

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 12

Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.

1 3 6

Michael G. Ison, MD MS @michaelisonmd.bsky.social · May 12

Michael Boeckh highlights the grow of the the @fredhutch Symposium on Infections - matching interest the field of #TxID

It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!

1 2 11

Reposted by Michael G. Ison, MD MS

ID Chief @ UMich @adamlauring.bsky.social · Apr 23

Really excited to be a part of this study and see it published today!

Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | New England Journal of Medicine www.nejm.org/doi/full/10....

Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | NEJM

Baloxavir marboxil (baloxavir) rapidly reduces influenza virus shedding, which suggests that it may reduce transmission. Studies of treatment with neuraminidase inhibitors have not shown sufficient...

www.nejm.org

2 14 53

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Apr 16

Adjuvanted RSV profusion F vaccine protection over 3 years - while VE declined over time, there remains significant protection against severe disease. More data is needed for longer term outcomes to inform optimal use.

The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · Apr 15

📈 New phase 3 data presented at #ESCMIDGlobal

Efficacy, safety, and immunogenicity of the #RSV prefusion F protein vaccine in older adults over three RSV seasons

Results support a beneficial effect for at least three RSV seasons

@michaelisonmd.bsky.social

🔗 tinyurl.com/5b87kh9x

1 4

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Apr 12

It was an honor to review the data on the link between Ureaplasma spp and Hyperammonemia in Lung Transplant recipients @ESCMID #ESCMIDGlobal 2025. Slides are here for those who want them.

www.dropbox.com/scl/fi/ei4ym...

www.dropbox.com

2 9

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Apr 12

A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal

1 4

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Apr 12

Great review of TB in endemic regions including approaches to use universal prophylaxis to reduce the incidence of post-transplant infection. @RubinaNaqvi1

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Apr 12

Great talk about HHV8 and the role of donor screening by Alesandra Mularone including follow-up management.

linkinghub.elsevier.com/retrieve/pii...

1 1

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Apr 11

It’s not to late to submit ideas for sessions @escmid.bsky.social Global 2026 for ESGICH to advocate for. Please follow the links below to submit ideas and sign up for the meeting to talk through the ideas!

Michael G. Ison, MD MS @michaelisonmd.bsky.social · Mar 19

ESGICH Planning Committee for 2026 ESCMID Global

This will be a small working group to help develop proposals for ESGICH to propose for the 2026 ESCMID Global Program. If you are interested in help, please complete the form below. This will be o...

forms.gle